Celularity Inc. (CELU)

Every figure this model derived for CELU, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 161,000 PaymentsToAcquirePropertyPlantAndEquipment 2024-12-31
cash 6,175,000 CashAndCashEquivalentsAtCarryingValue 2025-12-31
current assets 12,319,000 AssetsCurrent 2025-12-31
current liabilities 80,759,000 LiabilitiesCurrent 2025-12-31
equity -38,062,000 StockholdersEquity 2025-12-31
interest expense 2,502,000 InterestPaidNet 2025-12-31
ocf -13,254,000 NetCashProvidedByUsedInOperatingActivities 2025-12-31
revenue 26,550,000 RevenueFromContractWithCustomerExcludingAssessedTax 2025-12-31
sbc 10,642,000 AllocatedShareBasedCompensationExpense 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up CELU on one particular measure came for.

RatioValue
cash operating margin-163.36
current ratio0.16
current ratio reported0.15
deferred revenue growth48.82
dilution pct16.95
fcf margin-50.53
growth cv2.18
interest cover-24.5
operating margin-230.92
owner earnings margin-90.61
revenue growth-51.03
revenue growth per share-58.13
rule of 40-281.95
sbc pct revenue40.08

What to be careful about

What this model itself distrusts about CELU's figures. Written by the derivation as it ran, not added afterwards.